(Press-News.org) HOUSTON-Researchers at The University of Texas MD Anderson Cancer Center and other institutions have applied a newly developed software tool to identify genetic mutations that contribute to a person's increased risk for developing common, complex diseases, such as cancer. The research is published in the May 2014 edition of the journal Nature Biotechnology.
The technology, known as pVAAST (pedigree Variant Annotation, Analysis and Search Tool), combines two different statistical methods used for identifying disease-causing gene mutations. This combination approach outperforms individual familial analysis methods by increasing power or speed in which mutations are identified, and reducing complications through study design and analysis.
"This method allows for faster, more efficient identification and validation of genetic variants that influence disease risk," Chad Huff, Ph.D., professor of Epidemiology at MD Anderson. "This will eventually enable clinical labs to design genetic tests that provide better predictions of a person's individual risk of developing cancer."
The pVAAST tool combines two commonly used disease-gene identification methods, linkage analysis and association tests. Linkage analysis tracks the inheritance of genetic mutations in families to identify possible causal mutations. Association tests compare unrelated individuals with a specific disease to healthy individuals in search of a common mutation in one group or the other.
"Linkage analysis and association tests were initially designed for sparse genetic markers available from earlier genotyping techniques," said lead author of the study, Hao Hu, Ph.D., a postdoctoral fellow of Epidemiology at MD Anderson. "pVAAST integrates these two methods and repurposes them for next-generation DNA sequencing data, which is the state-of-art technique for genetics research. It fills in a genuine gap between molecular techniques and computational tools in familial disease studies."
Researchers also incorporated functional variant prioritization into the tool, which predicts whether a particular mutation in a family is damaging.
For this particular study, pVAAST analyzed data to identify the genetic causes of three diseases; enteropathy – a chronic inflammation of the intestine, cardiac septal defects and Miller Syndrome – a developmental defect of the face and multiple limbs. The tool was able to identify the exact mutations causing these diseases from DNA data from a single family. In the cardiac septal defects and Miller Syndrome families, the casual mutations had previously been identified and the results served as a proof of concept. In the enteropathy family, the causal mutation in the family was unknown prior to the analysis.
In addition, researchers applied pVAAST and three other statistical methods to three models of genetic disease: dominant, in which one defected copy of the gene is inherited from a parent; recessive, in which both copies of the gene must have the defect; or dominant caused by a new mutation not inherited from either parent. In each case, pVAAST required a fraction of the sample size of families to detect disease risk as the other methods did.
"For most rare diseases it is challenging to collect DNA samples from multiple patients," said Huff. "This makes it essential to be able to incorporate relatives in a study to improve the success rate."
In this study, the combined methodology of using multiple statistical methods increased the power of the results and reduced the complexity of the analysis. "This provides a gateway to identifying genetic variants that influence the risk of developing specific cancers," said Huff.
Many ongoing genetic studies recruit patients with a family history of cancer to search for inherited mutations that increase the risk of developing cancer. Huff says this tool will allow researchers to analyze the sequence data from these families to identify the genetic variants that are most likely responsible for the history of cancer in the families.
Huff says moving forward the major focus for the software will be to uncover new cancer-susceptibility genes. In a separate paper published in Cancer Discovery, the software was used to support the discovery of RINT1 as a new breast-cancer susceptibility gene.
"The identification of potential cancer susceptibility genes is only a first step, and years of additional research are required to characterize these variants to conclusively establish the degree to which they influence cancer risk," said Huff.
INFORMATION:
Co-authors with Huff and first author Hu are Shankaracharya, Ph.D., and Paul Scheet, Ph.D., both of MD Anderson; Jared Roach, Ph.D., Gustavo Glusman, Ph.D., Robert Hubley, Ph.D., Hong Li, Ph.D., and Leroy Hood, Ph.D., all of Institute for Systems Biology; Mark Yandell, Ph.D., Hilary Coon, Ph.D,, Stephen Guthery, M.D., Sean Tavtigian, Ph.D., Wilfred Wu, M.D., Ph.D., Lynn Jorde, Ph.D., Barry Moore and Karl Voelkerding, M.D., all of the University of Utah; Shuoguo Wang, Ph.D. and Jinchuan Xing, Ph.D., both of Rutgers, The State University of New Jersey; Rebecca Margraf, Ph.D. and Jacob Durtschi, both of ARUP Institute for Clinical and Experimental Pathology; Vidu Garg, M.D., of Ohio State University; David Galas, Ph.D., of the University of Luxembourg; Deepak Srivastava, M.D., of Gladstone Institute of Cardiovascular Disease and the University of California; and Martin Reese, Ph.D., of Omicia, Inc. END
New software tool identifies genetic mutations that influence disease risk
Unique, robust method uses family data to find mutations for both common and rare diseases
2014-05-30
ELSE PRESS RELEASES FROM THIS DATE:
Study links urbanization and future heat-related mortality
2014-05-30
TEMPE, Ariz. – Phoenix stands at a parched crossroads. Global scale climate change is forecast to bring hotter summers and more extreme heat to the Valley, but regional urbanization also will impact temperatures experienced by residents.
So how should Phoenix grow knowing that such growth could cause temperatures to increase in the future and bring added health risks? Should the city deploy mitigating technologies to help fight summer's heat? Would adopting a low-growth strategy reduce the adverse health consequences of hot weather?
New Arizona State University research ...
DNA-binding fluorescent dyes detect real-time cell toxicity during drug screening
2014-05-30
New Rochelle, NY, May 30, 2014—High throughput screening of compounds in live cells is a powerful approach for discovering new drugs, but the potential for cell toxicity must be considered. A novel technique that uses DNA-binding fluorescent dyes to evaluate the cytotoxicity of an experimental compound in real-time during screening, saving time and resources, is described in ASSAY and Drug Development Technologies, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the ASSAY and Drug Development Technologies website.
Lucius Chiaraviglio ...
Study explains how green tea could reduce pancreatic cancer risk
2014-05-30
LOS ANGELES – (May 30, 2014) – Green tea and its extracts have been widely touted as potential treatments for cancer, as well as several other diseases. But scientists have struggled to explain how the green tea and its extracts may work to reduce the risk of cancer or to slow the growth of cancer cells.
A study recently published online by the journal, Metabolomics, offers an explanation that researchers say could open a new area of cancer-fighting research. The study reports that EGCG, the active biologic constituent in green tea, changed the metabolism of pancreatic ...
Research shows overall survival benefit for patients with Stage III soft tissue sarcomas
2014-05-30
CHICAGO, IL (May 30, 2014)—Fox Chase Cancer Center researchers have carried out the first retrospective analysis of adjuvant chemotherapy's impact on overall survival in patients with stage III soft tissue sarcomas (STS), adjusted for socioeconomic status and other variables. The findings show that regardless of socioeconomic status and comorbidities, adjuvant chemotherapy improved survival by approximately 23 percent in stage III STS. Study leader Sujana Movva, MD, Medical Oncologist at Fox Chase, will present the findings the 50th Annual Meeting of the American Society ...
More patients with ovarian cancer are receiving chemotherapy before surgery
2014-05-30
CHICAGO, IL (May 30, 2014)—The use of chemotherapy before surgery to remove ovarian cancer has increased dramatically in recent decades, particularly among certain patients, according to a new analysis from Fox Chase Cancer Center that will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
Looking back at medical records from more than 58,000 women, Fox Chase's Angela Jain, MD, Medical Oncologist and co-investigator Elizabeth Handorf, PhD, member of the Biostatistics and Bioinformatics Facility, found that only 8.94% received chemotherapy ...
Compounds in saliva and common body proteins may fend off DNA-damaging chemicals
2014-05-30
A compound in saliva, along with common proteins in blood and muscle, may protect human cells from powerful toxins in tea, coffee and liquid smoke flavoring, according to results of a new study led by investigators at the Johns Hopkins Kimmel Cancer Center.
The findings, reported online May 19 in Food and Chemical Toxicology, suggest that people naturally launch multiple defenses against plant chemicals called pyrogallol-like polyphenols or PLPs found in teas, coffees and liquid smoke flavoring. The presence of these defenses could help explain why PLPs are not crippling ...
New satellite animation shows the end of Hurricane Amanda
2014-05-30
VIDEO:
This animation of visible and infrared imagery from NOAA's GOES-West satellite shows the weakening of Hurricane Amanda from May 28 to its dissipation on May 30.
Click here for more information.
A new animation of visible and infrared imagery from NOAA's GOES-West satellite shows the weakening and dissipation of the Eastern Pacific Ocean's Hurricane Amanda. The animation that runs from from May 28 to May 30 was created at NASA/NOAA's GOES Project at NASA's Goddard Space ...
Hepatitis C reactivation doesn't worsen survival for HIV+ patients diagnosed with lymphoma
2014-05-30
CHICAGO, IL (May 30, 2014)—More than a quarter of HIV+ patients are also infected with the Hepatitis C virus (HCV), which may complicate treatment and care decisions after a cancer diagnosis. The specifics of those complications haven't been well-researched in the past. Results from a new Fox Chase Cancer Center study on this patient population may start filling in that gap.
Fox Chase Hematologist and Medical Oncologist Stefan K. Barta, MD, MS, MRCP – who led the study – analyzed data from HIV+ patients diagnosed with lymphoma, collected over 17 years, to better understand ...
Identification of central nervous system involvement for patients with AIDS-related lymphomas
2014-05-30
CHICAGO, IL (May 30, 2014)—Patients with AIDS-related lymphomas (ARL) may face an increased risk of central nervous system involvement (CNSi) compared to other lymphomas. The effect of CNSi on survival outcomes, however, hasn't been thoroughly examined until now.
In a new study led by Fox Chase Cancer Center Hematologist and Oncologist Stefan K. Barta, MD, MS, MRCP, researchers report that CNSi – identified at the time of an ARL diagnosis – does not appear to have an impact on overall survival. Dr. Barta's collaborators will present the findings at the 50th Annual Meeting ...
Moffitt Cancer Center instrumental in new clinical guidelines for cancer-related fatigue
2014-05-30
TAMPA, Fla. (May 30, 2014) – Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life. Approximately 30 percent of cancer patients endure persistent fatigue for several years after treatment, according to an American Society of Clinical Oncology Expert Panel co-chaired by Paul Jacobsen, Ph.D., associate center director of Population Sciences at Moffitt Cancer Center.
ASCO created the panel to develop assessment, screening, and treatment guidelines for ...
LAST 30 PRESS RELEASES:
Sensing sickness
Cost to build multifamily housing in California more than twice as high as in Texas
Program takes aim at drinking, unsafe sex, and sexual assault on college campuses
Inability to pay for healthcare reaches record high in U.S.
Science ‘storytelling’ urgently needed amid climate and biodiversity crisis
KAIST Develops Retinal Therapy to Restore Lost Vision
Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response
Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid
Low LDL cholesterol levels linked to reduced risk of dementia
Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients
Almost one in ten people surveyed report having been harmed by the NHS in the last three years
Enhancing light control with complex frequency excitations
New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients
New insight into factors associated with a common disease among dogs and humans
Illuminating single atoms for sustainable propylene production
New study finds Rocky Mountain snow contamination
Study examines lactation in critically ill patients
UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award
Doubling down on metasurfaces
New Cedars-Sinai study shows how specialized diet can improve gut disorders
Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana
PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation
ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy
How VR technology is changing the game for Alzheimer’s disease
A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet
Balance between two competing nerve proteins deters symptoms of autism in mice
Use of antifungals in agriculture may increase resistance in an infectious yeast
Awareness grows of cancer risk from alcohol consumption, survey finds
The experts that can outsmart optical illusions
Pregnancy may reduce long COVID risk
[Press-News.org] New software tool identifies genetic mutations that influence disease riskUnique, robust method uses family data to find mutations for both common and rare diseases